CHINALI, MARCELLO
 Distribuzione geografica
Continente #
NA - Nord America 2.920
AS - Asia 2.580
EU - Europa 1.992
SA - Sud America 307
AF - Africa 59
Continente sconosciuto - Info sul continente non disponibili 33
OC - Oceania 5
Totale 7.896
Nazione #
US - Stati Uniti d'America 2.814
SG - Singapore 1.295
RU - Federazione Russa 859
VN - Vietnam 448
CN - Cina 400
SE - Svezia 260
BR - Brasile 235
HK - Hong Kong 201
DE - Germania 169
FI - Finlandia 124
UA - Ucraina 109
FR - Francia 107
IT - Italia 102
IE - Irlanda 98
CA - Canada 63
NL - Olanda 61
IN - India 47
GB - Regno Unito 43
BD - Bangladesh 41
AR - Argentina 33
JP - Giappone 28
ZA - Sudafrica 27
IQ - Iraq 24
AT - Austria 22
MX - Messico 22
PL - Polonia 13
TR - Turchia 12
CO - Colombia 11
PK - Pakistan 11
TH - Thailandia 11
ID - Indonesia 9
PH - Filippine 9
EC - Ecuador 8
VE - Venezuela 8
ES - Italia 7
MA - Marocco 7
JO - Giordania 6
TW - Taiwan 6
CI - Costa d'Avorio 5
KR - Corea 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
DO - Repubblica Dominicana 4
PY - Paraguay 4
CG - Congo 3
CL - Cile 3
CZ - Repubblica Ceca 3
GE - Georgia 3
IL - Israele 3
JM - Giamaica 3
PE - Perù 3
SN - Senegal 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
BE - Belgio 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
HN - Honduras 2
HR - Croazia 2
LT - Lituania 2
LY - Libia 2
MD - Moldavia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
RO - Romania 2
SV - El Salvador 2
AG - Antigua e Barbuda 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GI - Gibilterra 1
HT - Haiti 1
IR - Iran 1
KH - Cambogia 1
KW - Kuwait 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
MG - Madagascar 1
MK - Macedonia 1
MY - Malesia 1
NI - Nicaragua 1
PR - Porto Rico 1
PT - Portogallo 1
TJ - Tagikistan 1
TV - Tuvalu 1
UY - Uruguay 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZW - Zimbabwe 1
Totale 7.865
Città #
Singapore 630
San Jose 408
Chandler 333
Moscow 223
Ashburn 196
Hong Kong 193
Jacksonville 157
Santa Clara 145
Ho Chi Minh City 133
Beijing 130
Millbury 95
Hanoi 93
Princeton 81
Los Angeles 68
Lauterbourg 60
Amsterdam 58
The Dalles 55
Council Bluffs 53
Dallas 51
Munich 51
Ann Arbor 50
Boston 49
Nanjing 47
Houston 39
Buffalo 38
Boardman 36
Kronberg 36
Woodbridge 35
New York 34
Wilmington 33
Ottawa 29
Helsinki 28
Tokyo 27
Seattle 26
Haiphong 25
Nanchang 20
Hefei 19
Pune 19
Da Nang 18
Falkenstein 18
Redondo Beach 18
São Paulo 18
Falls Church 16
Rio de Janeiro 16
Shenyang 16
Turku 15
Washington 14
Changsha 13
Baghdad 12
Dong Ket 12
Johannesburg 12
Mexico City 12
Warsaw 12
Atlanta 11
Chicago 11
Hebei 11
Montreal 11
Naples 11
Nuremberg 11
Vienna 11
Brooklyn 10
Hải Dương 10
Belo Horizonte 9
Can Tho 9
Denver 9
Frankfurt am Main 9
Biên Hòa 8
Chennai 8
Dublin 8
Kunming 8
Tianjin 8
Norwalk 7
Phoenix 7
Amman 6
Ankara 6
Elk Grove Village 6
London 6
Napoli 6
Orem 6
San Francisco 6
Toronto 6
Jiaxing 5
Milan 5
Mountain View 5
Poplar 5
Thái Nguyên 5
Vancouver 5
Bangkok 4
Boydton 4
Brasília 4
Bến Tre 4
Calgary 4
Cape Town 4
Jakarta 4
Louisville 4
Tashkent 4
Asunción 3
Bogotá 3
Bắc Giang 3
Bắc Ninh 3
Totale 4.338
Nome #
Preclinical Systolic Dysfunction In Patients With Stage 3 Chronic Renal Disease 156
Increased Left ventricular Mass and Control of Arterial Hypertension in Hypertensive Patients 149
Statins and Incident Diabetes 144
Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities 139
Left Venticular Hypertrophy and Carotid Atherosclerosis as Predictors of New-Onset Diabetes 137
Insufficient control of blood pressure and incident diabetes 136
Association of suboptimal blood pressure control with body size and metabolic abnormalities. 134
Left Ventricular Mass Is a Predictor of Follow-Up Uncontrolled Blood Pressure in Hipertensive Patients. 131
Estimate of White-coat Effect and Arterial Stiffness 130
Predictors of Lack of Regression of Left Ventricular Hypertrophy in Treated Hypertensive Patients. 130
Association of Blood Pressure With Blood Viscosity in American Indians. The Strong Heart Study 129
Preclinical Systolic Dysfunction in Patients with Stage 3 Chronic Renal Disease. 129
Evaluation of concentric Left Ventricular Geometry in Humans: Evidence for Age-Related Systematic Underestimation 128
Relationship between Myocardial Mechanical Efficiency and Cardiac Phenotype in Hypertensive Adults: the Campania Salute Network. 128
New-onset diabetes and uncontrolled blood pressure 126
2D Speckle Strain Immaging Identifies Depressed Left Atrial function in Hypertensive Patients with Diastolic Dysfunction 125
Risk factors for arterial hypertension in adults with initial optimal bloodpressure: the Strong Heart Study. 123
Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated framingham risk score in individuals with dyslipidemia. 121
Does Additional Echocardiographic Information Improve Prediction of Cardiovascular Event by Left Ventricular Hypertrophy in Arterial Hypertension? 120
Impact of obesity on cardiac geometry and function in a population of adolescents: the Strong Heart Study. 118
Increased left ventricular mass in pre-liver transplantation cirrhotic patients. 118
Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension? 118
Atrial Strain by 2d Speckle Tracking Outperforms Atrial Volume in Identifying Hypertensive Patients with Diastolic Dysfunction 118
Atrial Strain by 2D Speckle Tracking Outperforms Atrial Volume in Identifying Hypertensive Patients with Diastolic Dysfunction 118
Non Invasive Evaluation of Myocardial Stiffness in Arterial Hypertension. 118
Association of Insuline Resistance with Preclinical Cardiovascular Disease in Adolescent and young Adults: the Strong Heart Study 117
Left ventricular concentric geometry is associated with impaired relaxation in hypertension: the HyperGEN study. 114
Incident Diabetes in Hypertensive Patients with Uncontrolled Blood Pressure 113
Statins therapy in atrial fibrillation in hypertensive patients. 113
Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study. 111
Cardiac markers of preclinical disease in adolescents with the metabolic syndrome: the strong heart study. 111
Myocardial mechano-energetic efficiency in hypertensive adults 111
Body composition and fat distribution influence systemic hemodynamics in the absence of obesity: the HyperGEN Study. 110
Reduced Systolic Myocardial Function in Children with Chronic Renal Insufficiency 110
Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study) 109
Impact of left ventricular geometry on myocardial mechanical efficiency in hypertensive patients 106
Left Atrial Systolic Force and Cardiac Markers of Preclinical Disease in Hypertensive Patients: the Hypertension Genetic Epidemiology Network (HyperGEN) Study 105
Prognostic Impact of Metabolic Syndrome by Different Definitions in a Population with High Prevalence of Obesity and Diabetes: The Strong Heart Study. 104
Aortic Dilatation in Normotensive or Hypertensive Adolescents and Young Adults: The Strong Heart Study 104
Correlation among renal and cardiac function and left ventricular geometries: The Strong Heart Study. 101
Left Atrial Systolic Force: Comparison Between Two Methods for the Noninvasive assesment of Left Atrial Systolic Function 97
Cardiac Remodeling and Diastolic Dysfunction Precede non MI-Related Heart Failure in High-Risk Hypertensive Patients: the LIFE Echo Substudy 96
Prevalence and Correlation of Aortic Dilatation in Adolescents and Young Adults: the Strong Heart Study 93
2d Speckle Strain Imaging Identifies Depressed Left Atrial Function in Hypertensive Patients with Diastolic Dysfunction 93
Sex Differences in Obesity-Related Changes in Left Ventricular Morphology : the Strong Heart Study. 92
Cardiovascular and metabolic predictors of progression to overt hypertension in a population with basal high-normal blood pressure levels: The Strong Heart Study 89
Metabolic and cardiovascular characteristics of diabetes in adolescents and young adults: the Strong Heart Study 89
Increased Left Ventricular Mass in Hypertensive Men Is More Strongly Related to Central than to Brachial Blood Pressure Control 89
Depressed Cardiac Mechanics in Hypertensive Patients with Moderate Chronic Renal Insufficiency: A Speckle-Strain Study 89
Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE Study. 86
Left ventricular mass and incident hypertension in individuals with initial optimal blood pressure: the strong heart study. 85
Addition of Canrenone to optimal therapy improves cardiac geometry and function in patients with systolic heart failure and metabolic syndrome: The AREA-IN-CHF Study 85
Impact of prescription of classes of antihypertensive medications on blood pressure control in the metabolic syndrome 84
Left Ventricular Mass Predicts Heart Failure not related to Previous Miocardial Infarction: The Cardiovascular Health Study. 83
Combination of left atrial size and function improves prediction of incident heart failure: The Strong Heart Study. 82
Two Dimensional Speckle Strain Imaging Identifies Depressed Left Atrial Function in Hypertensive Patients with Diastolic Dysfunction 81
Hypokalemia blunts left ventricular mass regression in hypertensive patients during Losartan- or Atenolol-based treatment: The LIFE Echo-substudy 80
The Issue of Body Size Between Methods and Substance. 76
Left ventricular mass, left ventricular pump performance and cardiovascular events: the Strong Heart Study 76
Mitral E Wave Deceleration Time to Peak E Velocity Ratio and Cardiovascular Outcome in Hypertensive Patients during Antihypertensive Treatment (from the LIFE Echo-Sbstudy) 75
Evidence for increased left ventricular chamber stiffness in type 2 diabetes: the Strong Heart Study. 75
Hypokalemia Blunts Left Ventricular Mass Regression in Hypertensive Patients During Losartan or Atenolol-Based Treatment: The Life Echo-Substudy 75
Diabetes and incident heart failure: The Strong Heart Study. 72
Cardiovascular Predictors of Incident Heart Failure in Diabetes: the Strong Heart Study 72
Relation of ventricular geometry and function to age-related decline of renal function in a population without kidney failure: The Strong Heart Study 71
Combination of left atrial size and function improves prediction of incident heart failure: the Strong Heart Study. 70
Development of systolic disfunction not related to myocardial infarction in treated hypertensive patients with left ventricular hypertrophy: the LIFE Echo Substudy 68
Cardiovascular phenotype predicting incident heart failure in diabetes: The Strong Heart Study. 68
Cardiac modifications related to incident heart failure in treated hypertensive patients: the LIFE Echo Substudy. 68
Partial normalization of components of metabolic syndrome does not influence echocardiographic abnormalities: The HyperGEN Study. 68
Diagnosis of metabolic syndrome based on history of exposure or present abnormalities: evidence of necessity of a better definition 65
Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: the strong heart study 64
Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study 63
Influence of non-haemodynamic factors of left ventricular mass in adolescents with High prevalence of obesity: The Strong Heart Study. 63
Mitral E wave deceleration time to peak E velocity ratio and cardiovascular outcome in hypertensive patients during anti-hypertensive treatment: the LIFE Eco-substudy. 59
Left ventricular mass, left ventricular pump performance and cardiovascular events: The Strong Heart Study. 59
Independent association of coronary flow reserve with left ventricular relaxation and filling pressure in arterial hypertension 59
Development of Systolic Dysfunction Not Related to Myocardial Infarction in Treated Hypertensive Patients With Left Ventricular Hypertrophy: The LIFE Echo Substud 58
Exaggerated left ventricular adaptive response to obesity in women 56
Esame standard per protocolli scientifici 54
null 7
Totale 7.896
Categoria #
all - tutte 26.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.806


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022382 0 2 1 5 1 11 0 13 96 11 46 196
2022/2023671 98 54 10 86 97 79 0 66 90 51 32 8
2023/2024381 12 52 20 24 38 73 2 63 0 12 67 18
2024/20251.975 94 98 14 44 19 152 205 121 140 188 659 241
2025/20263.405 362 258 309 249 631 203 417 135 377 317 91 56
2026/202788 80 8 0 0 0 0 0 0 0 0 0 0
Totale 7.896